Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Surgery
    October 2024
  1. RAMOS-FRESNEDO A, Phillips AL, Cantrell MC, Mobley EM, et al
    Cancer recurrence and survival among patients who underwent neoadjuvant treatment and surgery for esophageal cancer: A single-institution 10-year experience.
    Surgery. 2024 Oct 25:S0039-6060(24)00838-9. doi: 10.1016/j.surg.2024.
    >> Share

  2. PROCOPIO PF, Pennestri F, Voloudakis N, La Rocca S, et al
    Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
    Surgery. 2024 Oct 24:S0039-6060(24)00809-2. doi: 10.1016/j.surg.2024.
    >> Share

  3. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone.
    Surgery. 2024 Oct 16:S0039-6060(24)00786-4. doi: 10.1016/j.surg.2024.
    >> Share

  4. JACOBS RC, Valukas CS, Visa MA, Logan CD, et al
    Association of operative time and approach on postoperative complications for esophagectomy.
    Surgery. 2024;176:1106-1114.
    >> Share

    September 2024
  5. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    >> Share

  6. YANG Y, Jiang C, Su Y, Pan J, et al
    Occurrence and recovery of vocal cord paralysis after minimally invasive McKeown esophagectomy, risk factors, and clinical outcome.
    Surgery. 2024;176:713-720.
    >> Share

    August 2024
  7. MACHENS A, Dralle H
    Response to letter to the editor on "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
    >> Share

  8. KIM LT
    Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
    >> Share

  9. JOGERST K, Zhang C, Chang YH, Gupta N, et al
    Dynamic volume-outcome association for esophagectomies: Do current volume thresholds still apply?
    Surgery. 2024;176:341-349.
    >> Share

  10. MATHIESEN MR, Piper TB, Olsen AA, Damtoft A, et al
    Textbook outcome after esophagectomy: A retrospective study from a high-volume center.
    Surgery. 2024;176:350-356.
    >> Share

    July 2024
  11. FEBRERO SANCHEZ B, Iborra E, Sanchez-Pedreno P, Ros-Madrid I, et al
    Analysis of the loss of phosphatase and tensin homolog expression in thyroid tissue for the diagnosis of Cowden syndrome.
    Surgery. 2024 Jul 6:S0039-6060(24)00384-2. doi: 10.1016/j.surg.2024.
    >> Share

  12. PALLEIKO BA, Dickson KM, Crawford A, Shafique S, et al
    Preoperative risk factors for anastomotic leak after esophagectomy with gastric reconstruction: A 6-year national surgical quality improvement (NSQIP) database analysis.
    Surgery. 2024;176:93-99.
    >> Share

  13. LEVENSON G, Coutrot M, Voron T, Gronnier C, et al
    Root cause analysis of mortality after esophagectomy for cancer: a multicenter cohort study from the FREGAT database.
    Surgery. 2024;176:82-92.
    >> Share

    June 2024
  14. HOELZEN JP, Fortmann L, Roy D, Szardenings C, et al
    Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience.
    Surgery. 2024 Jun 29:S0039-6060(24)00323-4. doi: 10.1016/j.surg.2024.
    >> Share

  15. KNIPPER K, Jung JO, Straatman J, Brunner S, et al
    The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.
    Surgery. 2024 Jun 28:S0039-6060(24)00292-7. doi: 10.1016/j.surg.2024.
    >> Share

  16. JIANG KY, Zhang SX, Hu WL, Deng ZQ, et al
    Prognostic factors for patients with pathologic T1-T2N+ esophageal squamous cell carcinoma: A retrospective study with external validation.
    Surgery. 2024 Jun 19:S0039-6060(24)00326-X. doi: 10.1016/j.surg.2024.
    >> Share

  17. FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
    Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
    >> Share

    May 2024
  18. XIAO X, Zhu Y, Li L, Liao Y, et al
    The effectiveness and safety of thermal ablation for thyroid carcinoma lymph node metastasis are affected by the diameter of metastatic lymph nodes: A meta-analysis.
    Surgery. 2024 May 21:S0039-6060(24)00233-2. doi: 10.1016/j.surg.2024.
    >> Share

  19. LUNARDI N, Jacob A, Elfenbein D, Schneider DF, et al
    Don't chase the adenoma: A probabilistic approach to imaging before parathyroidectomy.
    Surgery. 2024;175:1299-1304.
    >> Share

  20. MA S, Zhu J, Xue M, Shen Y, et al
    Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study.
    Surgery. 2024;175:1305-1311.
    >> Share

    April 2024
  21. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    >> Share

  22. CHALLINE A, Kirouani M, Markar SR, Tzedakis S, et al
    MIRO study: Do the results of a randomized controlled trial apply in a real population?
    Surgery. 2024;175:1055-1062.
    >> Share

    March 2024
  23. PIERCE K, Philips P, Egger ME, Scoggins CR, et al
    Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients.
    Surgery. 2024;175:718-725.
    >> Share

    February 2024
  24. DYAS AR, Mungo B, Bronsert MR, Stuart CM, et al
    National trends in technique use for esophagectomy: Does primary surgeon specialty matter?
    Surgery. 2024;175:353-359.
    >> Share

  25. DU J, Zeng T, Zhang S, Chen M, et al
    Comparison of indocyanine green-near-infrared fluorescence guided and traditional mediastinal lymphadenectomy during radical esophagectomy: A randomized controlled trial.
    Surgery. 2024;175:347-352.
    >> Share

  26. FUJITA T, Sato K, Fujiwara N, Kajiyama D, et al
    A novel imaging technology to assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy.
    Surgery. 2024;175:360-367.
    >> Share

    January 2024
  27. HEO DB, Won HR, Tae K, Kang YE, et al
    Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
    >> Share

  28. LUND S, Schmitz JJ, Foster T, Dy B, et al
    Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
    Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
    >> Share

  29. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    >> Share

  30. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    >> Share

    December 2023
  31. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    >> Share

  32. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    >> Share

  33. OWUSU-BRACKETT N, Chakedis JM, Dedhia P, Gilliam C, et al
    Efficacy and safety of near-infrared fluorescence identification of the thoracic duct during left lateral neck dissection.
    Surgery. 2023 Dec 5:S0039-6060(23)00683-9. doi: 10.1016/j.surg.2023.
    >> Share

    November 2023
  34. SZABO YAMASHITA T, Shirali AS, Meas S, Sarli V, et al
    Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
    Surgery. 2023 Nov 21:S0039-6060(23)00636-0. doi: 10.1016/j.surg.2023.
    >> Share

  35. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    >> Share

  36. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    >> Share

  37. SWANSON J, Roat-Shumway S, Cohn T, Luchette FA, et al
    Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?
    Surgery. 2023 Nov 4:S0039-6060(23)00518-4. doi: 10.1016/j.surg.2023.
    >> Share

  38. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    >> Share

  39. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    >> Share

    October 2023
  40. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    >> Share

  41. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    >> Share

  42. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    >> Share

  43. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    >> Share

  44. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    >> Share

  45. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    >> Share

  46. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    >> Share

    September 2023
  47. VERM RA, Baker MM, Cohn T, Park S, et al
    Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Surgery. 2023 Sep 22:S0039-6060(23)00504-4. doi: 10.1016/j.surg.2023.
    >> Share

  48. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    >> Share

  49. SCHURING N, Donlon NE, Hagens ERC, Gootjes D, et al
    External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer.
    Surgery. 2023 Sep 19:S0039-6060(23)00502-0. doi: 10.1016/j.surg.2023.
    >> Share

  50. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Corrigendum to "Long-term survival and prognostic factors associated with curative conversion surgery for cT4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases": Surgery. 2023 Sep;174(3):558-566. doi:10.1016/j.surg.2023.05.040.
    Surgery. 2023 Sep 5:S0039-6060(23)00528-7. doi: 10.1016/j.surg.2023.
    >> Share

    August 2023
  51. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    >> Share

  52. LAYDI M, Doussot A, Lakkis Z, Mathieu P, et al
    Anatomic patterns of anastomotic leaks after Ivor Lewis esophagectomy for cancer: Impact on management and outcomes.
    Surgery. 2023;174:247-251.
    >> Share

    July 2023
  53. ZHANG J, Wang Y, Zhang T, Xu D, et al
    A clinical nomogram for predicting small bowel obstruction after extubation after radical resection of esophageal cancer and jejunostomy.
    Surgery. 2023 Jul 24:S0039-6060(23)00404-X. doi: 10.1016/j.surg.2023.
    >> Share

    June 2023
  54. STEVENS A, Meier J, Bhat A, Knight SJ, et al
    Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
    Surgery. 2023 Jun 29:S0039-6060(23)00328-8. doi: 10.1016/j.surg.2023.
    >> Share

  55. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases.
    Surgery. 2023 Jun 28:S0039-6060(23)00335-5. doi: 10.1016/j.surg.2023.
    >> Share

    May 2023
  56. KUO TC, Chen KY, Lai CW, Wang YC, et al
    Synergic evacuation device helps smoke control during endoscopic thyroid surgery.
    Surgery. 2023 May 16:S0039-6060(23)00187-3. doi: 10.1016/j.surg.2023.
    >> Share

    March 2023
  57. KANG YJ, Stybayeva G, Hwang SH
    Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer: A network meta-analysis.
    Surgery. 2023 Mar 25:S0039-6060(23)00110-1. doi: 10.1016/j.surg.2023.
    >> Share

  58. SWANSON J, Littau M, Tonelli C, Cohn T, et al
    The role of endoscopic resection in early-stage esophageal adenocarcinoma: Esophagectomy is associated with improved survival in patients presenting with clinical stage T1bN0 disease.
    Surgery. 2023;173:693-701.
    >> Share

    February 2023
  59. OGUMA J, Ishiyama K, Kurita D, Kanematsu K, et al
    Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa.
    Surgery. 2023 Feb 15:S0039-6060(22)01086-8. doi: 10.1016/j.surg.2022.
    >> Share

  60. QURESHI MM, Kam A, Suzuki K, Litle V, et al
    Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer.
    Surgery. 2023 Feb 9:S0039-6060(22)01080-7. doi: 10.1016/j.surg.2022.
    >> Share

    January 2023
  61. DAS S, Jha CK, Singh PK
    Extent of surgery in localized, sporadic medullary thyroid carcinoma: Can we avoid central compartment lymph node dissection?
    Surgery. 2023 Jan 11:S0039-6060(22)01043-1. doi: 10.1016/j.surg.2022.
    >> Share

  62. WRIGHT K, Brandler TC, Fisher JC, Rothberger GD, et al
    The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
    Surgery. 2023;173:239-245.
    >> Share

  63. BAREGAMIAN N, Sekhar KR, Krystofiak ES, Vinogradova M, et al
    Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications.
    Surgery. 2023;173:67-75.
    >> Share

    December 2022
  64. THAKUR PS, Kumar C
    Critical appraisal of total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Surgery. 2022 Dec 15:S0039-6060(22)00994-1. doi: 10.1016/j.surg.2022.
    >> Share

  65. WALLER GC, Patel DJ, Baker MS
    Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy?
    Surgery. 2022;172:1753-1758.
    >> Share

    November 2022
  66. CARTY SE
    Real-time thyroid nodule care.
    Surgery. 2022 Nov 7. pii: S0039-6060(22)00849-2. doi: 10.1016/j.surg.2022.
    >> Share

  67. UNDERWOOD HJ, Mott NM, Saucke MC, Roman BR, et al
    What do patients want to know about surgery for low-risk thyroid cancer? A qualitative study.
    Surgery. 2022 Nov 3. pii: S0039-6060(22)00725-5. doi: 10.1016/j.surg.2022.
    >> Share

  68. KUO EJ, Oh A, Hu Y, McManus CM, et al
    If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules.
    Surgery. 2022 Nov 2. pii: S0039-6060(22)00800-5. doi: 10.1016/j.surg.2022.
    >> Share

  69. HUMPHREYS BM, Memeh KO, Funkhouser A, Vaghaiwalla TM, et al
    Prognostic factors and survival analysis of Hurthle cell carcinoma: A population-based study.
    Surgery. 2022;172:1379-1384.
    >> Share

    October 2022
  70. FINN CB, Wirtalla C, Mascuilli T, Krumeich LN, et al
    Simulated data-driven hospital selection for surgical treatment of well-differentiated thyroid cancer in older adults.
    Surgery. 2022 Oct 21. pii: S0039-6060(22)00724.
    >> Share

  71. LIU JB, Ramonell KM, Carty SE, McCoy KL, et al
    Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes.
    Surgery. 2022 Oct 19. pii: S0039-6060(22)00723.
    >> Share

  72. WOODS RSR, Fitzgerald CWR, Valero C, Lopez J, et al
    Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: Is lobectomy enough?
    Surgery. 2022 Oct 15. pii: S0039-6060(22)00720.
    >> Share

  73. RAMONELL KM, Ohori NP, Liu JB, McCoy KL, et al
    Changes in thyroid nodule cytology rates after institutional implementation of the Thyroid Imaging Reporting and Data System.
    Surgery. 2022 Oct 14. pii: S0039-6060(22)00802.
    >> Share

  74. DELMAN AM, Turner KM, Ammann AM, Sisak S, et al
    The national rate of malignancy among Bethesda III, IV, and V thyroid nodules is higher than expected: A NSQIP analysis.
    Surgery. 2022 Oct 11. pii: S0039-6060(22)00685.
    >> Share

  75. MA EZ, Kuo JH, Malek R, Turner DJ, et al
    Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Surgery. 2022 Oct 5. pii: S0039-6060(22)00674-2. doi: 10.1016/j.surg.2022.
    >> Share

  76. BARRANCO H, Fazendin J, Lindeman B, Chen H, et al
    Thyroid hormone replacement following lobectomy: Long-term institutional analysis 15 years after surgery.
    Surgery. 2022 Oct 3. pii: S0039-6060(22)00677-8. doi: 10.1016/j.surg.2022.
    >> Share

    September 2022
  77. CHIU AS, Saucke MC, Bushaw K, Voils CI, et al
    The relative importance of treatment outcomes to surgeons' recommendations for low-risk thyroid cancer.
    Surgery. 2022 Sep 28. pii: S0039-6060(22)00320.
    >> Share

  78. FRISCO NA, Gunn AH, Thomas SM, Stang MT, et al
    Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Surgery. 2022 Sep 20. pii: S0039-6060(22)00323.
    >> Share

    August 2022
  79. CONROY PC, Wilhelm A, Calthorpe L, Ullmann TM, et al
    Endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines.
    Surgery. 2022 Aug 21. pii: S0039-6060(22)00498.
    >> Share

  80. LIANG W, Shi J, Zhang H, Lv G, et al
    Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis.
    Surgery. 2022 Aug 19. pii: S0039-6060(22)00489.
    >> Share

  81. BEER A, Reber A, Paireder M, Schoppmann SF, et al
    Tumor cell budding in preoperative biopsies of esophageal and gastroesophageal junction carcinoma independently predicts survival in a grade-dependent manner.
    Surgery. 2022;172:567-574.
    >> Share

    July 2022
  82. ABE T, Oshikiri T, Goto H, Kato T, et al
    Thoracic cavity-to-cage ratio is a predictor of technical difficulties in minimally invasive esophagectomy.
    Surgery. 2022;172:145-149.
    >> Share

  83. GOOSZEN JAH, Eshuis WJ, Blom RLGM, van Dieren S, et al
    The effect of preoperative body mass index on short-term outcome after esophagectomy for cancer: A nationwide propensity score-matched analysis.
    Surgery. 2022;172:137-144.
    >> Share

    June 2022
  84. FUJITA H, Motoyama S, An J, Nagakai Y, et al
    Peritumoral CD16b positive-neutrophil accumulation strongly correlates with regional lymph node metastasis in thoracic esophageal squamous cell cancer.
    Surgery. 2022;171:1535-1542.
    >> Share

    May 2022
  85. PAI E, Kumar T
    Intrathoracic versus cervical anastomosis in esophagectomy for esophageal cancer: Are these procedures indeed comparable?
    Surgery. 2022 May 31. pii: S0039-6060(22)00310.
    >> Share

  86. HAMAI Y, Emi M, Ibuki Y, Murakami Y, et al
    Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy.
    Surgery. 2022 May 3. pii: S0039-6060(22)00218-5. doi: 10.1016/j.surg.2022.
    >> Share

  87. PRASAD P, Wallace L, Navidi M, Phillips AW, et al
    Learning curves in minimally invasive esophagectomy: A systematic review and evaluation of benchmarking parameters.
    Surgery. 2022;171:1247-1256.
    >> Share

    April 2022
  88. YOU J, Zhang H, Li W, Dai N, et al
    Intrathoracic versus cervical anastomosis in esophagectomy for esophageal cancer: A meta-analysis of randomized controlled trials.
    Surgery. 2022 Apr 7. pii: S0039-6060(22)00149-0. doi: 10.1016/j.surg.2022.
    >> Share

    March 2022
  89. DING AS, Xie DX, Zhang L, Creighton FX, et al
    Public perceptions of radiofrequency ablation versus standard surgery for benign thyroid nodules.
    Surgery. 2022 Mar 2. pii: S0039-6060(22)00062-9. doi: 10.1016/j.surg.2022.
    >> Share

    February 2022
  90. GRAVES CE, Hope TA, Suh I
    Response to "Preoperative localization in primary hyperparathyroidism: Views from the developing world".
    Surgery. 2022;171:564.
    >> Share

  91. TYAGI N, Gaurav K, Anand A, Sonkar AA, et al
    Preoperative localization in primary hyperparathyroidism: Views from developing world.
    Surgery. 2022;171:563-564.
    >> Share

  92. KOSHY RM, Brown JM, Chmelo J, Watkinson T, et al
    Anastomotic stricture after Ivor Lewis esophagectomy: An evaluation of incidence, risk factors, and treatment.
    Surgery. 2022;171:393-398.
    >> Share

    January 2022
  93. BABAZADEH NT, Sinclair TJ, Krishnamurthy V, Jin J, et al
    Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
    Surgery. 2022;171:155-159.
    >> Share

  94. YAP A, Hope TA, Graves CE, Kluijfhout W, et al
    A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.
    Surgery. 2022;171:55-62.
    >> Share

  95. GRAVES CE, Hope TA, Kim J, Pampaloni MH, et al
    Superior sensitivity of (18)F-fluorocholine: PET localization in primary hyperparathyroidism.
    Surgery. 2022;171:47-54.
    >> Share

  96. SHARIQ OA, Lines KE, English KA, Jafar-Mohammadi B, et al
    Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.
    Surgery. 2022;171:77-87.
    >> Share

    December 2021
  97. ANGERAMO CA, Bras Harriott C, Casas MA, Schlottmann F, et al
    Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis.
    Surgery. 2021;170:1692-1701.
    >> Share

    November 2021
  98. YOU JY, Park DW, Anuwong A, Kim HY, et al
    Reply to "Prevention of transoral thyroidectomy complications: An analysis of surgical outcomes in 423 consecutive series."
    Surgery. 2021 Nov 19. pii: S0039-6060(21)01047.
    >> Share

  99. KUO JH, Sinclair CF, Lang B, Spiezia S, et al
    A comprehensive review of interventional ablation techniques for the management of thyroid nodules and metastatic lymph nodes.
    Surgery. 2021 Nov 11. pii: S0039-6060(21)00853.
    >> Share

  100. TVERSKOV V, Wiesel O, Solomon D, Orgad R, et al
    The impact of cervical anastomotic leak after esophagectomy on long-term survival of patients with esophageal cancer.
    Surgery. 2021 Nov 6. pii: S0039-6060(21)00969-7. doi: 10.1016/j.surg.2021.
    >> Share

  101. LYNCH CA, Bethi M, Tang A, Lee P, et al
    Thyroid nodules >4 cm with atypia of undetermined significance cytology independently associate with malignant pathology.
    Surgery. 2021 Nov 3. pii: S0039-6060(21)00787-X. doi: 10.1016/j.surg.2021.
    >> Share

  102. LINHARES SM, Handelsman R, Picado O, Farra JC, et al
    Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients.
    Surgery. 2021;170:1364-1368.
    >> Share

  103. WATTS F, Palme CE, Porceddu S, Sundaresan P, et al
    Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
    Surgery. 2021;170:1467-1473.
    >> Share

    October 2021
  104. ZHANG Y, Wang K, Liu J, Xu S, et al
    Surgical management of parapharyngeal lymph node metastases from thyroid carcinoma with transcervical approach.
    Surgery. 2021 Oct 25. pii: S0039-6060(21)00876.
    >> Share

  105. MACKINNEY EC, Kuchta KM, Winchester DJ, Khokar AM, et al
    Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
    Surgery. 2021 Oct 16. pii: S0039-6060(21)00796.
    >> Share

    September 2021
  106. THIESMEYER JW, Limberg J, Ullmann TM, Greenberg JA, et al
    Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma.
    Surgery. 2021 Sep 30. pii: S0039-6060(21)00794.
    >> Share

  107. MACHENS A, Kaatzsch P, Lorenz K, Horn LC, et al
    Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.
    Surgery. 2021 Sep 30. pii: S0039-6060(21)00765.
    >> Share

  108. HARRIES V, McGill M, Yuan A, Wang LY, et al
    Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?
    Surgery. 2021 Sep 29. pii: S0039-6060(21)00863.
    >> Share

  109. KELZ RR
    Thyroid surgery: surgical health equity, best practices in surgical education, and leveraging the power of collaboration.
    Surgery. 2021 Sep 25. pii: S0039-6060(21)00855.
    >> Share

  110. HOLM TM, Bian ZC, Manupati K, Guan JL, et al
    Inhibition of autophagy mitigates cell migration and invasion in thyroid cancer.
    Surgery. 2021 Sep 23. pii: S0039-6060(21)00795.
    >> Share

  111. BONA D, Lombardo F, Matsushima K, Cavalli M, et al
    Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis.
    Surgery. 2021 Sep 17. pii: S0039-6060(21)00844.
    >> Share

  112. GREENBERG JA, Thiesmeyer JW, Ullmann TM, Egan CE, et al
    Association of the Affordable Care Act with access to highest-volume centers for patients with thyroid cancer.
    Surgery. 2021 Sep 3. pii: S0039-6060(21)00685-1. doi: 10.1016/j.surg.2021.
    >> Share

  113. GENPENG L, Pan Z, Tao W, Rixiang G, et al
    Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
    Surgery. 2021 Sep 2. pii: S0039-6060(21)00701-7. doi: 10.1016/j.surg.2021.
    >> Share

    August 2021
  114. AHN JH, Kwak JH, Yoon SG, Yi JW, et al
    A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
    Surgery. 2021 Aug 12. pii: S0039-6060(21)00611.
    >> Share

  115. HOLOUBEK SA, MacKinney EC, Khokar AM, Kuchta KM, et al
    Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Surgery. 2021 Aug 10. pii: S0039-6060(21)00571.
    >> Share

  116. YOUSSEF MR, Attia AS, Omar M, Aboueisha M, et al
    Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
    Surgery. 2021 Aug 10. pii: S0039-6060(21)00576.
    >> Share

  117. BECK AC, Rajan A, Landers S, Kelley S, et al
    Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
    Surgery. 2021 Aug 3. pii: S0039-6060(21)00653-X. doi: 10.1016/j.surg.2021.
    >> Share

  118. KWAK MS, Eun YG, Lee YC
    Benefit of postoperative radiotherapy in patients with oropharyngeal squamous cell carcinoma in human papillomavirus (HPV) era: A Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Surgery. 2021;170:541-549.
    >> Share

    July 2021
  119. LI C, Lopez B, Fligor S, Broekhuis JM, et al
    Long-term voice changes after thyroidectomy: Results from a validated survey.
    Surgery. 2021 Jul 31. pii: S0039-6060(21)00686.
    >> Share

  120. ZHAO B, Aggarwal A, Marshall JA, Barletta JA, et al
    Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
    Surgery. 2021 Jul 29. pii: S0039-6060(21)00572.
    >> Share

  121. KIM J, Sun Z, Cummins M, Donohue KC, et al
    Implications of radiofrequency ablation in patients undergoing thyroid surgery for benign disease in the United States.
    Surgery. 2021 Jul 22. pii: S0039-6060(21)00616.
    >> Share

  122. DELMAN AM, Turner KM, Ammann AM, Tang A, et al
    Avoiding delays in time to renal transplantation: Pretransplant thyroid malignancy does not affect patient or graft survival after renal transplantation.
    Surgery. 2021 Jul 21. pii: S0039-6060(21)00455.
    >> Share

  123. SZABO YAMASHITA T, Rogers RT, Foster TR, Lyden ML, et al
    Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?
    Surgery. 2021 Jul 18. pii: S0039-6060(21)00570.
    >> Share

  124. LIU Z, Li Y, Wang Y, Xiang C, et al
    Comparison of the transoral endoscopic thyroidectomy vestibular approach and open thyroidectomy: A propensity score-matched analysis of surgical outcomes and safety in the treatment of papillary thyroid carcinoma.
    Surgery. 2021 Jul 17. pii: S0039-6060(21)00643.
    >> Share

  125. HU QL, Schumm MA, Zanocco KA, Yeh MW, et al
    Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules.
    Surgery. 2021 Jul 17. pii: S0039-6060(21)00555.
    >> Share

  126. FENG JW, Qu Z, Ye J, Hong LZ, et al
    Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Surgery. 2021 Jul 15. pii: S0039-6060(21)00635.
    >> Share

  127. SHARMA RK, Lee J, Liou R, McManus C, et al
    Optimal surgeon-volume threshold for neck dissections in the setting of primary thyroid malignancies.
    Surgery. 2021 Jul 12. pii: S0039-6060(21)00541.
    >> Share

  128. TAKAHASHI C, Shridhar R, Huston J, Blinn P, et al
    Comparative outcomes of transthoracic versus transhiatal esophagectomy.
    Surgery. 2021;170:263-270.
    >> Share

    June 2021
  129. KARZAI S, Zhang Z, Sutton W, Prescott J, et al
    Ambient particulate matter air pollution is associated with increased risk of papillary thyroid cancer.
    Surgery. 2021 Jun 28. pii: S0039-6060(21)00415.
    >> Share

  130. CREPEAU PK, Kulkarni K, Martucci J, Lai V, et al
    Comparing surgical thoroughness and recurrence in thyroid cancer patients across race/ethnicity.
    Surgery. 2021 Jun 11. pii: S0039-6060(21)00412.
    >> Share

  131. LUI DTW, Fung MMH, Lee CH, Fong CHY, et al
    A territory-wide assessment of the incidence of persistent hypoparathyroidism after elective thyroid surgery and its impact on new fracture risk over time.
    Surgery. 2021 Jun 8. pii: S0039-6060(21)00423-2. doi: 10.1016/j.surg.2021.
    >> Share

  132. YOU JY, Kim H, Park DW, Yang HW, et al
    Prevention of transoral thyroidectomy complications: An analysis of surgical outcomes in 423 consecutive series.
    Surgery. 2021 Jun 2. pii: S0039-6060(21)00422-0. doi: 10.1016/j.surg.2021.
    >> Share

    May 2021
  133. LEE J, Ha EJ, Roh J, Kim HK, et al
    Presence of TERT +/- BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.
    Surgery. 2021 May 2. pii: S0039-6060(21)00317-2. doi: 10.1016/j.surg.2021.
    >> Share

  134. MORITANI S, Takenobu M, Yoshioka K, Kawamoto K, et al
    Novel surgical methods for reconstruction of the recurrent laryngeal nerve: Microscope-guided partial layer resection and intralaryngeal reconstruction of the recurrent laryngeal nerve.
    Surgery. 2021;169:1124-1130.
    >> Share

    April 2021
  135. TANAKA K, Yamasaki M, Kobayashi T, Yamashita K, et al
    Postoperative pneumonia in the acute phase is an important prognostic factor in patients with esophageal cancer.
    Surgery. 2021 Apr 29. pii: S0039-6060(21)00312.
    >> Share

  136. KRISHNA A, Mishra A, Mishra SK
    Comment on: Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
    Surgery. 2021 Apr 26. pii: S0039-6060(21)00236.
    >> Share

  137. OLIVER JR, Patel KN, Chang CM, Baldwin CK, et al
    Lymph node metastases in pediatric medullary thyroid carcinoma.
    Surgery. 2021 Apr 7. pii: S0039-6060(21)00193-8. doi: 10.1016/j.surg.2021.
    >> Share

  138. ZAYDFUDIM VM
    Postoperative complications and long-term health-related quality of life (HRQOL) after esophagectomy.
    Surgery. 2021;169:988.
    >> Share

    February 2021
  139. CHOW KY, Kurumety S, Helenowski IB, Giri S, et al
    Association between quality of life and patient-reported complications from surgery and radioiodine in early-stage thyroid cancer survivors: A matched-pair analysis.
    Surgery. 2021 Feb 26. pii: S0039-6060(21)00060.
    >> Share

  140. ZHANG X, Jiang L, Liu L, Liu B, et al
    Influence of body mass index at diagnosis on outcome of thyroid cancer in children and adolescents.
    Surgery. 2021 Feb 18. pii: S0039-6060(21)00029.
    >> Share

    January 2021
  141. LANG BH, Fung MMH
    Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism.
    Surgery. 2021;169:109-113.
    >> Share

    November 2020
  142. SHAHA AR, Tuttle RM
    Commentary: Re-recurrence after surgical management of recurrent thyroid cancer.
    Surgery. 2020 Nov 26. pii: S0039-6060(20)30743.
    >> Share

    September 2020
  143. SCHUMM MA, Ohev-Shalom R, Nguyen DT, Kim J, et al
    Measuring patient perceptions of surgeon communication performance in the treatment of thyroid nodules and thyroid cancer using the communication assessment tool.
    Surgery. 2020 Sep 24. pii: S0039-6060(20)30551.
    >> Share

    August 2020
  144. WEBB C, Cronin P, Gupta N, Verhey J, et al
    Is thyroid cancer prognosis affected by solid organ transplantation?
    Surgery. 2020 Aug 16. pii: S0039-6060(20)30443.
    >> Share

  145. HU X, Saunders N, Safley S, Smith MR, et al
    Environmental chemicals and metabolic disruption in primary and secondary human parathyroid tumors.
    Surgery. 2020 Aug 5. pii: S0039-6060(20)30370-6. doi: 10.1016/j.surg.2020.
    >> Share

    July 2020
  146. SUBRAMANIAN C, Gorney R, Wang T, Ge D, et al
    A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro.
    Surgery. 2020 Jul 24. pii: S0039-6060(20)30369.
    >> Share

  147. BORTZ MD, Kuchta K, Winchester DJ, Prinz RA, et al
    Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
    Surgery. 2020 Jul 15. pii: S0039-6060(20)30183.
    >> Share

  148. DOUBLEDAY AR, Robbins SE, Macdonald CL, Elfenbein DM, et al
    What is the experience of our patients with transient hypoparathyroidism after total thyroidectomy?
    Surgery. 2020 Jul 9. pii: S0039-6060(20)30238-5. doi: 10.1016/j.surg.2020.
    >> Share

    May 2020
  149. SUTTON W, Genberg B, Prescott JD, Segev DL, et al
    Understanding surgical decision-making in older adults with differentiated thyroid cancer: A discrete choice experiment.
    Surgery. 2020 May 28. pii: S0039-6060(20)30165.
    >> Share

  150. CRAIG S, Khalil M, Eszlinger M, Itani D, et al
    Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts.
    Surgery. 2020 May 26. pii: S0039-6060(20)30184.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016